Related references
Note: Only part of the references are listed.Review article: the role of non-biological drugs in refractory inflammatory bowel disease
S. C. Ng et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Successive Treatment With Cyclosporine and Infliximab in Steroid-Refractory Ulcerative Colitis
S. Leblanc et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Infliximab Rescue Therapy after Cyclosporin Failure in Steroid-Refractory Ulcerative Colitis
Miriam Manosa et al.
DIGESTION (2009)
Role of medical rescue therapy in the management of acute severe ulcerative colitis: the surgical perspective
Walter A Koltun
Expert Review of Gastroenterology & Hepatology (2009)
Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis
Elana A. Maser et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Steroid-refractory severe ulcerative colitis - What are the available treatment options?
Alan C. Moss et al.
DRUGS (2008)
Time trends of mortality from Crohn's disease and ulcerative colitis
Amnon Sonnenberg
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2007)
Elective and emergent operative management of ulcerative colitis
Amanda M. Metcalf
SURGICAL CLINICS OF NORTH AMERICA (2007)
Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis
D. Hahnloser et al.
BRITISH JOURNAL OF SURGERY (2007)
Response to corticosteroids in severe ulcerative colitis: A systematic review of the literature and a meta-regression
Dan Turner et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Systematic review: infliximab therapy in ulcerative colitis
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis
A. Waljee et al.
GUT (2006)
Predictors of clinical response to systemic steroids in active ulcerative colitis
Isabel Bernal et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis:: A randomized, placebo-controlled study
G Järnerot et al.
GASTROENTEROLOGY (2005)
Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease
J Kountouras et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2004)
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis
G Van Assche et al.
GASTROENTEROLOGY (2003)
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis:: a randomised controlled trial
CSJ Probert et al.
GUT (2003)
Diagnosis and management of pouchitis
U Mahadevan et al.
GASTROENTEROLOGY (2003)
Suppressive effects of cyclosporine A on neutrophils and T cells may be related to therapeutic benefits in patients with steroid-resistant ulcerative colitis
K Ina et al.
INFLAMMATORY BOWEL DISEASES (2002)
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: A pilot study
BE Sands et al.
INFLAMMATORY BOWEL DISEASES (2001)
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis
G D'Haens et al.
GASTROENTEROLOGY (2001)